Bio-Techne Corp
TECH · NASDAQ · Pharmaceuticals, Biotech · Founded 1976
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Current Price
$72.71
Market Cap
$11.4B
Return Since Last Split
+18%
Last Split
Nov 30, 2022
Total Splits
3
Cumulative Multiple
16×
What If You Bought TECH Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$116,336
1,600 shares · 16×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Nov 30, 2022 | $81.77 | 4-for-1 | 4× | 16× |
| Dec 4, 2000 | — | 2-for-1 | 2× | 4× |
| Nov 18, 1997 | — | 2-for-1 | 2× | 2× |
Bio-Techne Corp Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 3 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Bio-Techne Corp's latest record in the split calendar is a 4-for-1 forward split effective 2022-11-30.